The Single-Session Principle: Changing Oral Biology, and What It Means for Implant Removal

When a patient asks me, “Can you remove my implant?”, I listen carefully to the question behind the question.

Sometimes the concern is pain, mobility, bleeding or repeated infection. Sometimes it is fear that the implant material itself is affecting the body. Sometimes another clinician has suggested removal, and the patient wants to understand whether taking the implant out will finally resolve the problem.

I ask the patient to pause before thinking only about the implant. Removal is an act. The oral environment in which that implant sits is the condition that made removal seem necessary. The first can be completed in a clinical appointment; the second may require a broader diagnosis, treatment and maintenance plan.

That distinction matters. Removing an implant may eliminate a colonised surface, a source of mechanical irritation or a component associated with inflammation. It does not automatically reset the ecology of the mouth. The more useful question is often not simply, “Should this implant come out?” but, “What is happening in the environment around it, and what must change for healing to become possible?”

The single-session principle

The single-session principle proposes that, where clinically appropriate, all significant necrotic, infected or unwanted metallic material should be addressed in one event. That might include a failing implant, compromised teeth, residual root material or retained metallic components contributing to the treatment problem.

The stated rationale is ecological. The mouth is not a collection of independent teeth and implants. It is a connected ecosystem containing biofilms, saliva, mucosal surfaces, periodontal pockets, restorations, healing tissues and a constantly changing microbial community. If only one part of the burden is removed, the remaining environment may continue to support the same pattern of inflammation and recolonisation.

The argument is that decisive treatment in one session gives the microbial community a different starting point. With separate appointments, the microbiome may reorganise only partially between interventions and reassert itself during the intervals. The principle therefore places importance on simultaneity: change the principal physical drivers at the same time, rather than repeatedly disturbing one area while leaving another untreated.

That logic is biologically coherent. Ecosystems can be altered by removing habitats, changing available nutrients or disrupting the relationships that allow particular organisms to persist. A peri-implant pocket, a rough contaminated surface and untreated periodontal disease may collectively provide conditions that support dysbiosis. Addressing several of those conditions together could, in theory, produce a more meaningful ecological disruption than addressing them one by one.

However, I must describe this honestly. The claim that a microbiome shift requires simultaneity, and does not occur with staged treatment, is the rationale of the therapeutic concept. It is not an established clinical finding.

The documented mechanism

The strongest part of this discussion is not the claim about one appointment. It is the evidence that titanium particles and ions can modify the local peri-implant environment in specific clinical contexts.

Studies have detected titanium in peri-implant tissues and plaque, particularly around diseased sites. In human research, higher titanium concentrations in peri-implant plaque have correlated with changes in the microbial community. Disease-associated profiles have included greater representation of genera such as Veillonella, alongside a decline in health-associated Streptococcus. Peri-implant disease has also been associated with changes in microbial diversity, including lower alpha diversity in some titanium-related observations.

The orange complex is relevant because it represents a group of organisms associated with periodontal and peri-implant disease progression. Research has identified enrichment of orange-complex organisms in some disease-associated microbial profiles, although the findings are not perfectly consistent across every study, sampling method or treatment protocol. I do not use one microbial group as a stand-alone diagnosis.

The mechanism should be understood as a loop rather than a straight line. Biofilm accumulation contributes to inflammation. Inflammation changes the local tissue environment and can accelerate corrosion or the release of metallic particles and ions. Those particles may further influence the microbial community and host response. The resulting dysbiosis can deepen inflammation, creating conditions for still more corrosion and particle release.

This does not mean that titanium is automatically the original cause of every peri-implant problem. In many cases, biofilm accumulation and inflammation create the conditions in which material release becomes more relevant. Nor does the presence of titanium particles prove that an implant must be removed. It means that the implant, its surface, the surrounding tissues and the microbiome must be considered together.

That is why the single-session principle has a reasonable biological instinct. It recognises that the contaminated surface, the surrounding tissues and the wider oral environment may be interacting. The mechanism is documented in the literature. The specific superiority of a single-session approach is not.

The honest limit

No study has been designed to test whether the proposed microbiome shift occurs only when treatment is performed in one session and fails to occur with carefully staged treatment.

That is the crucial limitation. The principle is plausible. It is consistent with what is known about ecological disruption. It may well be right in selected circumstances. But plausibility is not proof, and presenting it as settled science would mislead patients and colleagues.

A study capable of answering the question would need clearly defined endpoints in both the peri-implant and salivary microbiome. It would need standardised sampling and sequencing methods, because different collection sites and laboratory approaches can produce different results. It would need comparable baseline disease severity between the single-session and staged groups. Researchers would also have to control, as far as possible, for antibiotic exposure, plaque-control routines, smoking, glycaemic status and other factors that influence the oral microbiome.

The follow-up would need to continue long enough to determine whether any ecological change was durable rather than a short-term response to surgery or antiseptic treatment. Most importantly, the study would need a genuine staged-treatment comparator arm. Without that comparison, the central claim cannot actually be tested.

Until such a study exists, I regard the single-session microbiome argument as clinical reasoning rather than measurement. I can explain why it makes sense. I cannot honestly tell a patient that it has been proven.

Sequencing matters more than material

The practical consequence is that sequencing may matter more than the material question patients initially bring to me.

Documented dysbiosis occurs around biofilm accumulation and inflammation. In many cases, peri-implant disease creates the conditions in which metal release becomes clinically relevant, rather than metal release being the first and only cause. Remove the implant while leaving the surrounding ecology unchanged, and the problem may persist in another form.

Plaque control still matters. So do dry mouth, glycaemic control, smoking, nutrition, tissue quality, periodontal disease and access for cleaning. The design of the future restoration matters. The patient’s ability to attend maintenance matters. The presence of untreated disease elsewhere in the mouth matters.

Ceramic dental implants also develop peri-implant disease. Zirconia does not immunise a patient against biofilm, inflammation or bone loss. Ceramic implants are not universally superior to titanium, and I do not present them as a clinical mandate.

There is also no validated diagnostic test for titanium hypersensitivity that can independently determine whether an implant should be removed. A patient may have a genuine concern about titanium, but the concern must be assessed alongside clinical findings, radiographs, symptoms, implant stability, tissue response and the overall treatment history.

If a patient prefers a metal-free reconstruction, I examine the proposed treatment component by component. “Metal-free” must be verified across the implant, abutment, framework, screws, attachments and other relevant parts. It should remain a patient preference after informed discussion, not a marketing claim or a universal clinical requirement.

The trade-off of concentrated treatment

Concentrating removal, reconstruction and immediate placement into one event carries a real trade-off. Every major decision must be correct the first time. There is no second look between stages, no interval in which to observe tissue response and no easy opportunity to revise an assumption before the next part of treatment begins.

A single session may be appropriate when an implant is mobile, non-restorable, severely malpositioned or associated with advanced circumferential bone loss. It may also be considered where persistent disease remains despite appropriate treatment and the risks and benefits have been examined carefully.

Staging may be safer when the diagnosis is uncertain, when infection needs to be controlled before reconstruction, when the patient’s systemic health requires optimisation or when tissue response needs to be observed. It may also be preferable when the implant remains stable and restorable, allowing conservative treatment or surgical decontamination to be assessed before irreversible removal.

Do not let convenience decide this question. Clinical judgement must come before commercial preference.

There is, however, a genuine argument for concentrated treatment. One recovery may be more manageable than several. Fewer anaesthetic exposures may be desirable. Patients may spend less time in a disrupted state, and those travelling from abroad may not be able to return repeatedly for appointments. These practical considerations are important, but they do not remove the need for appropriate case selection.

If a patient travels from abroad for zygomatic or ceramic implant surgery, I require a clear commitment to follow-up care and a local clinician who can provide maintenance afterwards. Complex treatment is not completed simply because the patient has returned home. Long-term monitoring, hygiene support and management of complications remain part of the treatment.

What should a patient ask?

Start by asking whether the implant is genuinely failing or whether the problem can still be treated. Ask how the diagnosis has been established and whether infection, mechanical overload, poor positioning, residual cement or inadequate access for cleaning has been considered.

Ask whether the rest of the mouth is being treated as part of the plan. An isolated implant procedure may be insufficient if periodontal disease, compromised teeth, smoking, dry mouth or poor plaque control remain unaddressed.

Ask whether a single-session or staged approach serves your circumstances better. Request a clear explanation of what would make one approach safer than the other, what could change during treatment and what would happen if the expected tissue condition is not found.

Ask what maintenance will involve afterwards. Ask how often reviews are required, who will provide local care if you are travelling and which findings would trigger intervention.

Finally, separate two questions that are often confused: “Will I need this implant removed?” and “Will you replace it on the same day?” The first concerns diagnosis and disease control. The second concerns anatomy, stability, infection, reconstruction and risk. They may have completely different answers.

Patients often begin with broad online searches, whether for a dental clinic in Singapore or for ceramic dental implants. That is understandable, but search terms and clinic language should not decide treatment. The assessment still needs to be clinical, evidence-informed and individualised, and ceramic implants should be discussed as one possible material choice rather than a guarantee.

The question I would like us to keep asking

The sequencing question is the clinically interesting one. The material question is only the smaller half of what many patients ask.

I do not regard implant removal as a universal answer to dysbiosis, and I do not regard ceramic or zirconia implants as universally superior to titanium. I regard the oral environment, the implant, the surrounding tissues, the patient’s biology and the long-term maintenance plan as connected parts of one decision.

For an assessment, contact Nuffield Dental.

This article provides general information only and is not a substitute for examination or personalised advice. It does not recommend removing any implant or changing any treatment plan without clinical assessment. The microbiome effects described are documented in the literature in specific contexts and do not predict an individual outcome. The single-session rationale is a therapeutic concept rather than a proven finding.

When you have chosen a single session over staged treatment in an immediate implant protocol, what actually drove that decision?